Taysha Gene Therapies Inc (TSHA) — Free Cash Flow Generation Index

Latest as of December 2022: 0.84x

Taysha Gene Therapies Inc (TSHA) has a Free Cash Flow Generation Index of 0.84x as of December 2022. Free cash flow of $11.97 Million represents 1% of operating cash flow ($14.28 Million). Read TSHA current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.84x

Free Cash Flow / Operating CF

Free Cash Flow

$11.97 Million

USD

Operating Cash Flow

$14.28 Million

USD

Capital Expenditures

$2.31 Million

USD

Taysha Gene Therapies Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Taysha Gene Therapies Inc across 1 annual periods. Explore capital reinvestment ratio of Taysha Gene Therapies Inc to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Taysha Gene Therapies Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for Taysha Gene Therapies Inc. For the full company profile including market capitalisation, see TSHA company net worth.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2019	1.00x	$135.00K	$135.00K	$82.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).